Eldelumab Completed Phase 2 Trials for Ulcerative Colitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00656890A Study of MDX-1100 in Subjects With Active Ulcerative Colitis